Loreley Carlos Agostinho Bragard

Loreley Carlos Agostinho Bragard

Auto-generated profile, based on publicly available information

Loreley Carlos Agostinho Bragard

Universidade do Estado do Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Brazilian Oral Research
Verified
Journal Article
Open access
LBLoreley Carlos Agostinho Bragard
Loreley Carlos Agostinho Bragard
MSManuela Rubim Camara Sete
Manuela Rubim Camara Sete
LFLiana Bastos Freitas-Fernandes
Liana Bastos Freitas-Fernandes
FSFlavio Roberto Sztajnbok
Flavio Roberto Sztajnbok
Carlos Marcelo FigueredoCarlos Marcelo Figueredo
Carlos Marcelo Figueredo
FBFernanda Brito
Fernanda Brito
The aim of this study was to characterize the salivary metabolomic profile in adolescents with juvenile systemic lupus erythematosus (jSLE). A total of 24 adolescents with jSLE (15.92 ± 2.06 years) and 12 systemically healthy controls (15.25 ± 2.7 years) were included in the study. Participants underwent rheumatologic testing and periodontal examination, with the recording of plaque index (PI), probing depth (PD), clinical attachment level (CAL), and bleeding on probing index (BPI). Unstimulated whole saliva was collected from both groups and stored at -80 ºC. The salivary proton nuclear magnetic resonance (1H-NMR) spectra were acquired in a spectrometer operating at 500 MHz. Partial least squared discriminant analysis (PLS-DA) and orthogonal PLS-DA (O-PLS-DA) were used for statistical analysis. Mean CAL and PI were significantly increased in the group with jSLE (p < 0.01). Patients with jSLE presented a significantly different salivary metabolic profile (accuracy = 0.54; R2 = 0.86; Q2 = -0.293), significantly higher salivary levels of N-acetyl sugars, and significantly reduced levels of phenylalanine, glycine, taurine, hydroxybutyrate, and valerate compared with healthy controls (p < 0.05). It is suggested that the salivary metabolomic profile analyzed by 1H NMR in patients with jSLE presents a different fingerprint that the systemically healthy subjects. Integrating the variation of metabolites with the identification of the metabolic pathways involved seems to provide a better understanding of the influence of systemic disease on salivary metabolites.